The cloning and characterization of the protein responsible for iodide uptake, the NIS [20], has opened the way to novel therapeutic strategies based on induction of iodide uptake ability in tumour cells by recovery the expression of the NIS gene. Here, SLC5A5 is linked to neoplasm.